160 related articles for article (PubMed ID: 34242422)
1. 'COVID arm' - histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine.
Kempf W; Kettelhack N; Kind F; Courvoisier S; Galambos J; Pfaltz K
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e730-e732. PubMed ID: 34242422
[No Abstract] [Full Text] [Related]
2. Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization.
Fernandez-Nieto D; Hammerle J; Fernandez-Escribano M; Moreno-Del Real CM; Garcia-Abellas P; Carretero-Barrio I; Solano-Solares E; de-la-Hoz-Caballer B; Jimenez-Cauhe J; Ortega-Quijano D; Fernandez-Guarino M
J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e425-e427. PubMed ID: 33783873
[No Abstract] [Full Text] [Related]
3. 'COVID vaccine arm' may present after both mRNA vaccines vaccination.
Gregoriou S; Kleidona IA; Tsimpidakis A; Nicolaidou E; Stratigos A; Rigopoulos D
J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e867-e868. PubMed ID: 34416053
[No Abstract] [Full Text] [Related]
4. Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines.
Xu J; Vanijcharoenkarn K; Sexton ME; Martin L; Lee FE; Kuruvilla ME
J Gen Intern Med; 2021 Oct; 36(10):3298-3300. PubMed ID: 34291376
[No Abstract] [Full Text] [Related]
5. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
Lindgren AL; Austin AH; Welsh KM
J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504
[TBL] [Abstract][Full Text] [Related]
6. [A red and swollen arm after vaccination for covid-19].
De Mik D; Schot LJ; Privé B
Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 34854640
[TBL] [Abstract][Full Text] [Related]
7. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
[TBL] [Abstract][Full Text] [Related]
8. A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
Speich B; Chammartin F; Smith D; Stoeckle MP; Amico P; Eichenberger AL; Hasse B; Schuurmans MM; Müller T; Tamm M; Dickenmann M; Abela IA; Trkola A; Hirsch HH; Manuel O; Cavassini M; Hemkens LG; Briel M; Mueller NJ; Rauch A; Günthard HF; Koller MT; Bucher HC; Kusejko K;
Trials; 2021 Oct; 22(1):724. PubMed ID: 34674742
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
11. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
[TBL] [Abstract][Full Text] [Related]
12. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
14. Severe Dyskinesia After Administration of SARS-CoV2 mRNA Vaccine in Parkinson's Disease.
Erro R; Buonomo AR; Barone P; Pellecchia MT
Mov Disord; 2021 Oct; 36(10):2219. PubMed ID: 34368991
[No Abstract] [Full Text] [Related]
15. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccine effectiveness among the staff of the Bologna Health Trust, Italy, December 2020-April 2021.
Giansante C; Stivanello E; Perlangeli V; Ferretti F; Marzaroli P; Musti MA; Pizzi L; Resi D; Saraceni S; Pandolfi P
Acta Biomed; 2021 Sep; 92(4):e2021270. PubMed ID: 34487060
[TBL] [Abstract][Full Text] [Related]
17. A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient.
Chang KM; Berlinrut I; Wallach FR
Transpl Infect Dis; 2021 Oct; 23(5):e13710. PubMed ID: 34339083
[No Abstract] [Full Text] [Related]
18. Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients.
Kaiser RA; Haller MC; Apfalter P; Kerschner H; Cejka D
Kidney Int; 2021 Sep; 100(3):697-698. PubMed ID: 34270945
[No Abstract] [Full Text] [Related]
19. [Not Available].
Klimek L; Chaker AM; Cuevas M
Laryngorhinootologie; 2021 Mar; 100(3):168-173. PubMed ID: 33482671
[TBL] [Abstract][Full Text] [Related]
20. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
